Allucent TX Competitors and Similar CompaniesClear all

Allucent TX's competitors and similar companies include Envigo, American Cancer Society, Cyteir Therapeutics and Indivumed.

	Allucent TX Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries.	Envigo Envigo is a company that provides research models and services.	American Cancer Society American Cancer Society (ACS) is an organization that specializes in cancer prevention.	Cyteir Therapeutics Cyteir Therapeutics is a company that develops medicines for the treatment of cancer.	Indivumed Indivumed is an oncology company developing individualized cancer therapy.
Founding Date	Founding Date 1994	Founding Date 2015	Founding Date 1913	Founding Date 2012	Founding Date 2002
Type	Type Subsidiary	Type Subsidiary	Type Private	Type Public	Type Private
Tags	Tags Healthcare clinical research oncology pharma therapy	Tags Healthcare biotech clinical research drug development genetics pharma	Tags Healthcare clinical research oncology therapy	Tags Healthcare biotech clinical research drug development oncology pharma therapy	Tags Healthcare clinical research oncology therapy
Locations	Locations Chicago, US HQ Scherpenheuvel Zichem, BE Sao Paulo, BR Montréal, CA Zagreb, HR Prague, CZ Paris, FR see more	Locations Indianapolis, US HQ Gannat, FR Jerusalem, IL Bresso, IT Desio, IT Udine, IT Horst, NL see more	Locations Kennesaw, US HQ Hagatna, GU Arecibo, PR Caguas, PR Mayagüez, PR Ponce, PR San Juan, PR see more	Locations Lexington, US HQ	Locations Hamburg, DE HQ Frederick, US
Employees	Employees 4831% decrease	Employees 503	Employees 7,754	Employees 4615% increase	Employees 964% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $768.1m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) €13m (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $442.5m (FY, 2021)	Cost of goods N/A	Cost of goods €8.2m (FY, 2020)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $325.6m (FY, 2021)	Gross profit N/A	Gross profit €4.8m (FY, 2020)
Net income	Net income N/A	Net income N/A	Net income $69.3m (FY, 2021)	Net income ($46.1m) (FY, 2022)	Net income (€21.2m) (FY, 2020)
Operating ⚠
Trademarks (US)	Trademarks (US) 3 (Jan, 2022)	Trademarks (US) N/A	Trademarks (US) 64 (Nov, 2023)	Trademarks (US) N/A	Trademarks (US) N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 76.7m	Total funding raised $ 48m